Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Race Oncology Ltd. ( (AU:RAC) ).
Racura Oncology Ltd has notified the market of a new selective share buy-back program covering its ordinary fully paid shares traded under the ASX code RAC. The move signals an active capital management initiative that may affect the company’s share structure and could be interpreted by investors as a sign of confidence in its valuation and long-term strategy.
The most recent analyst rating on (AU:RAC) stock is a Hold with a A$2.00 price target. To see the full list of analyst forecasts on Race Oncology Ltd. stock, see the AU:RAC Stock Forecast page.
More about Race Oncology Ltd.
Racura Oncology Ltd (ASX: RAC) is an oncology-focused company listed on the Australian Securities Exchange, with its primary securities being ordinary fully paid shares. The company operates in the healthcare and biotechnology sector, concentrating on cancer-related therapies and related oncology initiatives for investors seeking exposure to this segment.
Average Trading Volume: 216,234
Technical Sentiment Signal: Buy
Current Market Cap: A$415.6M
For a thorough assessment of RAC stock, go to TipRanks’ Stock Analysis page.